Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
CONTEXT: Although metformin has been shown to be effective in the treatment of anovulation in women with polycystic ovary syndrome (PCOS), clomiphene citrate (CC) is still considered to be the first-line drug to induce ovulation in these patients. OBJECTIVE: The goal of this study was to compare the effectiveness of metformin and CC administration as a first-line treatment in anovulatory women with PCOS. DESIGN: We describe a prospective parallel randomized, double-blind, double-dummy controlled clinical trial. SETTING: The study was conducted at the University "Magna Graecia" of Catanzaro, Catanzaro, Italy. PATIENTS: One hundred nonobese primary infertile anovulatory women with PCOS participated. INTERVENTIONS: We administered metformin cloridrate (850 mg twice daily) plus placebo (group A) or placebo plus CC (150 mg for 5 d from the third day of a progesterone withdrawal bleeding) (group B) for 6 months each. MEAN OUTCOME MEASURES: The main outcome measures were ovulation, pregnancy, abortion, and live-birth rates. RESULTS: The subjects of groups A (n = 45) and B (n = 47) were studied for a total of 205 and 221 cycles, respectively. The ovulation rate was not statistically different between either treatment group (62.9 vs. 67.0%, P = 0.38), whereas the pregnancy rate was significantly higher in group A than group B (15.1 vs. 7.2%, P = 0.009). The difference found between groups A and B regarding the abortion rate was significant (9.7 vs. 37.5%, P = 0.045), whereas a positive trend was observed for the live-birth rate (83.9 vs. 56.3%, P = 0.07). The cumulative pregnancy rate was significantly higher in group A than group B (68.9 vs. 34.0%, P < 0.001). CONCLUSIONS: Six-month metformin administration is significantly more effective than six-cycle CC treatment in improving fertility in anovulatory nonobese PCOS women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and there is no evidence-based need to continue metformin in these individuals (92)(93)(94).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [93]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“None of the currently available human insulin preparations have been demonstrated to cross the placenta (93-98).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [93]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Nugent, D., Vanderkerchove, P., Hughes, E., Arnot, M., & Lilford, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000410.pub2 · Cited by 80
RetractedClomiphene citrate for ovulation induction in women with oligo-amenorrhoea
Hughes, E. G., Collins, J. A., & Vandekerckhove, P. (1996) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000056 · Cited by 75
Retracted(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Hirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,014
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Franks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 806
Clark, A. M., Thornley, B., Tomlinson, L., Galletley, C., & Norman, R. J. (1998) · Human Reproduction · doi:10.1093/humrep/13.6.1502 · Cited by 789
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
Lord, J. M., Flight, I. H. K., & Norman, R. J. (2003) · BMJ · doi:10.1136/bmj.327.7421.951 · Cited by 786
Cited by
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063971 · Cited by 1,027
Tang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub5 · Cited by 698
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
Broekmans, F., Knauff, E., Valkenburg, O., Laven, J., Eijkemans, M., & Fauser, B. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01008.x · Cited by 442
Palomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Self-citation14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s013 · Cited by 332
Metformin for the treatment of the polycystic ovary syndrome
Nestler, J. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0707092 · Cited by 313
Morley, L. C., Tang, T., Yasmin, E., Norman, R. J., & Balen, A. H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub6 · Cited by 296
Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications
Diamanti-Kandarakis, E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000598 · Cited by 294
“Endocrinol Metab 90, 4068-4074 138 Romualdi, D. et al. (2003) Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome. Hum Reprod 18, 1210–1218 139 Brettenthaler, N. et al. (2004) Effect of the insulin sensitizer pioglitazone…”
BackgroundInfluential15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s014 · Cited by 268
14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s014 · Cited by 265
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
Diamanti-Kandarakis, E., Christakou, C. D., Kandaraki, E., & Economou, F. N. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0733 · Cited by 247
Morin-Papunen, L., Rantala, A. S., Unkila-Kallio, L., Tiitinen, A., Hippeläinen, M., Perheentupa, A., Tinkanen, H., Bloigu, R., Puukka, K., Ruokonen, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3061 · Cited by 243
“fully and improve fertility outcomes (10, 18).”
Result15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232
Furat Rencber, S., Kurnaz Ozbek, S., Eraldemır, C., Sezer, Z., Kum, T., Ceylan, S., & Guzel, E. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0427-7 · Cited by 229
The role of metformin in polycystic ovary syndrome: a systematic review
Moll, E., van der Veen, F., & van Wely, M. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm026 · Cited by 188
“Metformin plus FSH compared with FSH alone In four randomised controlled trials, FSH plus metformin was compared with FSH alone in 154 infertile women with PCOS (Table 1) (Yarali et al., 2002; Tasdemir et al., 2004; Palomba et al., 2005a,b; van Santbrink et al., 2005).”
InfluentialPenzias, A., Bendikson, K., Butts, S., Coutifaris, C., Falcone, T., Fossum, G., Gitlin, S., Gracia, C., Hansen, K., La Barbera, A., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.026 · Cited by 181
Basic Infertility Including Polycystic Ovary Syndrome
Brassard, M., AinMelk, Y., & Baillargeon, J.-P. (2008) · Medical Clinics of North America · doi:10.1016/j.mcna.2008.04.008 · Cited by 180
“The cumulative rate of ovulation after 6 months in the metformin group was only 29%, as compared with 63% and 55% in the two studies from Palomba and colleagues [152,153] and 58% after 3 to 6 months in a meta-analysis of four randomized controlled trials [150].”
Result13. Management of Diabetes in Pregnancy
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s016 · Cited by 179
Review: Role of metformin in the management of polycystic ovary syndrome
Lashen, H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810380215 · Cited by 173
“were not representative of the PCOS population [Palomba et al. 2005], i.”
BackgroundResultMetformin use in women with polycystic ovary syndrome.
JOHNSON, N. P. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.04.15 · Cited by 145
Cassina, M., Donà, M., Di Gianantonio, E., Litta, P., & Clementi, M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu022 · Cited by 143
“…exposed to metformin prior to or during the first trimester of pregnancy; all of these publications were excluded from the meta-analysis since there was overlap with other studies or because data on birth defects were lacking (Palomba et al., 2004, 2005a, c, d, 2006, 2007, 2009a, 2010, 2011a, b).”
BackgroundResultInfluentialPregnancy complications in PCOS
Homburg, R. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.03.009 · Cited by 142
“Two further smaller trials compared, firstly, the use of metformin versus laparoscopic ovarian diathermy of the ovaries for clomiphene resistant PCOS women who were overweight [28] and then metformin versus clomiphene in non-obese anovulatory PCOS [ 29 ].”
ResultWang, R., Li, W., Bordewijk, E. M., Legro, R. S., Zhang, H., Wu, X., Gao, J., Morin-Papunen, L., Homburg, R., König, T. E., et al. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz029 · Cited by 137
Palomba, S., Falbo, A. I., Orio, F., & Zullo, F. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.087 · Cited by 147
The management of insulin resistance in polycystic ovary syndrome
Teede, H. J., Hutchison, S. K., & Zoungas, S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.08.001 · Cited by 135
Wang, R., Kim, B. V., van Wely, M., Johnson, N. P., Costello, M. F., Zhang, H., Ng, E. H. Y., Legro, R. S., Bhattacharya, S., Norman, R. J., et al. (2017) · BMJ · doi:10.1136/bmj.j138 · Cited by 133
Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
Sharpe, A., Morley, L. C., Tang, T., Norman, R. J., & Balen, A. H. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013505 · Cited by 132
The Harbin Consensus Conference Workshop Group, Chairs:, C., Legro, R. S., Wu, X., Scientific Committee:, Barnhart, K. T., Farquhar, C., Fauser, B. C. J. M., Mol, B., Legro, R. S., et al. (2014) · Human Reproduction · doi:10.1093/humrep/deu218 · Cited by 129
Self-citationDrug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal
Dunaif, A. E. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0787 · Cited by 131
Insulin resistance and polycystic ovary syndrome
Galluzzo, A., Amato, M. C., & Giordano, C. S. D. S. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.05.004 · Cited by 137
Use of clomiphene citrate in infertile women: a committee opinion
(2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.033 · Cited by 146
Legro, R. S., Myers, E. R., Barnhart, H. X., Carson, S. A., Diamond, M. P., Carr, B. R., Schlaff, W. D., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.037 · Cited by 122
Tan, S., Hahn, S., Benson, S., Dietz, T., Lahner, H., Moeller, L. C., Schmidt, M., Elsenbruch, S., Kimmig, R., Mann, K., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0294 · Cited by 112
Palomba, S., Falbo, A., Orio, F., Manguso, F., Russo, T., Tolino, A., Annamaria, C., Dale, B., & Zullo, F. (2005) · Human Reproduction · doi:10.1093/humrep/dei130 · Cited by 106
“…administered alone or associated in a sequential or combined regimen, ∼10% and ∼50% of women with PCOS remain, respectively, anovulatory or fail to conceive having ovulated on clomiphene citrate and/or metformin treatment (Hughes et al., 2000; Palomba et al., 2004b; Palomba et al., 2005).”
BackgroundZain, M. M., Jamaluddin, R., Ibrahim, A., & Norman, R. J. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.002 · Cited by 117
Tang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub4 · Cited by 101
Palomba, S., Pasquali, R., Orio, F., & Nestler, J. E. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03369.x · Cited by 100
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 176
Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
Gorry, A., White, D. M., & Franks, S. (2006) · Endocrine · doi:10.1385/endo:30:1:27 · Cited by 114
Panidis, D., Tziomalos, K., Papadakis, E., Vosnakis, C., Chatzis, P., & Katsikis, I. (2013) · Endocrine · doi:10.1007/s12020-013-9971-5 · Cited by 93
“In contrast, metformin appears to be more effective in improving fertility in non-obese patients with PCOS [70].”
BackgroundNeveu, N., Granger, L. R., St-Michel, P., & Lavoie, H. B. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.05.069 · Cited by 103
Roland, A. V., & Moenter, S. M. (2011) · Endocrinology · doi:10.1210/en.2010-0823 · Cited by 92
Diagnosis and Management of Polycystic Ovary Syndrome: A Practical Guide
Stankiewicz, M. T., & Norman, R. J. (2006) · Drugs · doi:10.2165/00003495-200666070-00002 · Cited by 103
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome
Palomba, S., Russo, T., Orio, F., Falbo, A., Manguso, F., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F. (2006) · Human Reproduction · doi:10.1093/humrep/dei351 · Cited by 85
“In a recent RCT, clomiphene citrate and metformin administration induced a similar correction of the ovulatory function in infertile PCOS women, whereas a higher improvement of fertility and reproductive outcome was detected after the latter treatment (Palomba et al., 2005a).”
BackgroundResultInfluentialSelf-citationSun, Y., Zhang, J., Xu, Y., Cao, Z.-Y., Wang, Y.-Z., Hao, G., & Gao, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.592495 · Cited by 98
“It is worth noting that the use of metformin before pregnancy may reduce the abortion rate (67, 68), but the evidence is insufficient.”
BackgroundPalomba, S., Orio, F., Falbo, A., Russo, T., Tolino, A., & Zullo, F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1009 · Cited by 83
“In addition, for simplifying the double-blind design and to limit the rate of CC-resistant patients, CC was administered at fixed dosages of 150 mg daily for six consecutive cycles ( 8 ).”
BackgroundMethodResultMisso, M. L., Costello, M. F., Garrubba, M., Wong, J., Hart, R., Rombauts, L., Melder, A. M., Norman, R. J., & Teede, H. J. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms036 · Cited by 81
“Palomba et al. (2005), in a high-quality RCT but with a small sample size, reported that metformin was statistically better than clomiphene citrate for pregnancy rate per cycle [Metformin ¼ 31/205 (15.1%), clomiphene citrate ¼ 16/221 (7.2”
InfluentialPrevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome
Glueck, C. J., Pranikoff, J., Aregawi, D., & Wang, P. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.03.036 · Cited by 90
Insulin Sensitivity after Metformin Suspension in Normal-Weight Women with Polycystic Ovary Syndrome
Palomba, S., Falbo, A., Russo, T., Manguso, F., Tolino, A., Zullo, F., De Feo, P., & Orio, F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0441 · Cited by 82
“Metformin administration restores ovulatory menstrual cycles and improves fertility in anovulatory PCOS women (9, 10 ), exerting beneficial effects on insulin sensitivity (9) and androgen and lipoprotein metabolism (9).”
BackgroundDehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats
Zhang, X., Zhang, C., Shen, S., Xia, Y., Yi, L., Gao, Q., & Wang, Y. (2013) · Human Reproduction · doi:10.1093/humrep/det341 · Cited by 91
“Metformin is an oral insulin sensitizer widely used for type 2 diabetes, and has been recommended for the treatment of anovular PCOS, mainly by reducing serum insulin levels and insulin resistance and improving ovulatory function (Palomba et al., 2005; Legro et al., 2007; Palomba et al., 2009).”
BackgroundDrug treatments for polycystic ovary syndrome.
Radosh, L. (2009) · PubMed · Cited by 114
Johnson, N. P., Stewart, A. W., Falkiner, J., Farquhar, C. M., Milsom, S., Singh, V. P., Okonkwo, Q. L., Buckingham, K. L., & on behalf of REACT-NZ (REproduction And Collaborative Trials in New Zealand), A. M.-C. F. T. G. (2010) · Human Reproduction · doi:10.1093/humrep/deq100 · Cited by 78
A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage
Cocksedge, K. A., Li, T.-C., Saravelos, S. H., & Metwally, M. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60304-5 · Cited by 73
Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective
Nestler, J. E. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.04.073 · Cited by 71
Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive review
Fernandez, H., Morin-Surroca, M., Torre, A., Faivre, E., Deffieux, X., & Gervaise, A. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.03.013 · Cited by 68
Glueck, C. J., Salehi, M., Sieve, L., & Wang, P. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.01.011 · Cited by 58
Palomba, S., Russo, T., Orio, F., Falbo, A., Manguso, F., Sammartino, A., Tolino, A., Colao, A., Carmina, E., & Zullo, F. (2006) · Human Reproduction · doi:10.1093/humrep/del267 · Cited by 58
“throughout treatment (Palomba et al., 2005) according to the fol-”
BackgroundMethodResultInfluentialThe Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome
Katsiki, N., Georgiadou, E., & Hatzitolios, A. I. (2009) · Drugs · doi:10.2165/00003495-200969110-00001 · Cited by 57
JOHNSON, N. (2011) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2010.01274.x · Cited by 53
DHEA-Mediated Inhibition of the Pentose Phosphate Pathway Alters Oocyte Lipid Metabolism in Mice
Jimenez, P. T., Frolova, A. I., Chi, M. M., Grindler, N. M., Willcockson, A. R., Reynolds, K. A., Zhao, Q., & Moley, K. H. (2013) · Endocrinology · doi:10.1210/en.2012-2140 · Cited by 52
Use of metformin in the treatment of polycystic ovary syndrome
Genazzani, A. D., Ricchieri, F., & Lanzoni, C. (2010) · Women's Health · doi:10.2217/whe.10.43 · Cited by 51
Tan, X., Li, S., Chang, Y., Fang, C., Liu, H., Zhang, X., & Wang, Y. (2016) · Clinical and Investigative Medicine · doi:10.25011/cim.v39i4.27091 · Cited by 51
“Moreover, some studies have found higher or similar ovulation and pregnancy rates following metformin treatment as compared to the clomiphene citrate (CC) [43-45], while the addition of meformin to CC monotherapy was reported to further enhance ovulation rate in a meta-analysis [46].”
ResultTang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub3 · Cited by 51
Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction
Petersen, K. B., Pedersen, N. G., Pedersen, A. T., Lauritsen, M. P., & Freiesleben, N. L. C. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.03.006 · Cited by 54
Sanchez-Garrido, M. A., Serrano-López, V., Ruíz-Pino, F., Vazquez, M. J., Rodríguez-Martín, A., Torres, E., Velasco, I., Rodríguez, A., Chicano‐Gálvez, E., Mora-Ortiz, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52898-y · Cited by 60
Siebert, T. I., Viola, M. I., Steyn, D. W., & Kruger, T. F. (2012) · Gynecologic and Obstetric Investigation · doi:10.1159/000335253 · Cited by 46
Insulin resistance and fertility in polycystic ovary syndrome.
Fica, S. V., Albu, A. I., Constantin, M., & Dobri, G. A. (2008) · Journal of Medicine and Life · Cited by 55
Jungheim, E. S., & Odibo, A. O. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.077 · Cited by 51
“52 (3, 5, 6) PrLBmetclomid Probability of live birth on metformin þ CC 0.”
BackgroundPalomba, S., Orio, F., Falbo, A. I., Russo, T., Tolino, A., & Zullo, F. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.05.035 · Cited by 50
Ghandi, S., Aflatoonian, A., Tabibnejad, N., & Moghaddam, M. H. S. (2011) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-011-9564-2 · Cited by 47
“In another short term study, 12 week use of metformin led to 73% ovulation [26].But 6 month use of metformin resulted in 62.9% [ 27 ], 55.4% ovulation [28].”
BackgroundInfluentialMetformin modulates IL-8, IL-1β, ICAM and IGFBP-1 expression in human endometrial stromal cells
Germeyer, A., Jauckus, J., Zorn, M., Tóth, B., Capp, E., & Strowitzki, T. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.11.006 · Cited by 49
“It has been shown to induce ovulation in women with otherwise anovulatory cycles, therefore enhancing fertility (Kashyap et al., 2004; Lord et al., 2003; Palomba et al., 2005).”
BackgroundPolycystic Ovary Syndrome and Insulin: Our Understanding in the Past, Present and Future
Mayer, S., Evans, W. S., & Nestler, J. E. (2015) · Women s Health · doi:10.2217/whe.14.73 · Cited by 60
Pregnancy Considerations in Women With Polycystic Ovary Syndrome
Legro, R. S. (2007) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31803057ed · Cited by 46
“5%), although the number of pregnant subjects in this trial as noted above was very small (N=31 in the metformin arm and N=16 in the clomiphene arm).(16) The metformin was stopped at the time of a positive pregnancy test.”
BackgroundPalomba, S., Falbo, A. I., Orio, F., Tolino, A., & Zullo, F. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.011 · Cited by 48
Hamed, H. O., Hasan, A. F., Ahmed, O. G., & Ahmed, M. A. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.08.033 · Cited by 41
RetractedWu, Y., Li, P., Zhang, D., & Sun, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5650 · Cited by 43
Magzoub, R., Kheirelseid, E. A. H., Perks, C. M., & Lewis, S. J. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.01.025 · Cited by 49
Glueck, C. J., Goldenberg, N., Pranikoff, J., Khan, Z., Padda, J., & Wang, P. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.755121 · Cited by 39
Froment, P., Plotton, I., Giulivi, C., Fabre, S., Khoueiry, R., Mourad, N. I., Horman, S., Ramé, C., Rouillon, C., Grandhaye, J., et al. (2022) · Human Reproduction · doi:10.1093/humrep/deac067 · Cited by 43
The insulin-resistant phenotype of polycystic ovary syndrome
Svendsen, P. F., Madsbad, S., & Nilas, L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.008 · Cited by 39
Rondanelli, M., Perna, S., Faliva, M. A., Monteferrario, F., Repaci, E., & Allieri, F. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3433-z · Cited by 53
“ized controlled trials (RCT) showed this positive effect of metformin therapy on endocrine and metabolic variables, not only in obese or insulin-resistant PCOS patients, but even in lean and insulin-sensitive women [27–31].”
BackgroundMetformin before and during pregnancy and lactation in polycystic ovary syndrome
Glueck, C. J., & Wang, P. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.2.191 · Cited by 36
“As metformin improves endocrinopathy in PCOS [4,6-8,10-13], it facilitates conception in women who, commonly, are infertile as well as clomifene resistant [14].”
BackgroundAbolhassani, N., Winterfeld, U., Kaplan, Y. C., Jaques, C., Minder, B., Giovane, C. D., & Panchaud, A. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002919 · Cited by 43
Kar, S., & Sanchita, S. (2015) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.170373 · Cited by 36
“[27] reported much higher LBR with metformin as compared to CC (52% vs.”
BackgroundTaking TRIPS to India — Novartis, Patent Law, and Access to Medicines
Mueller, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068245 · Cited by 44
Palomba, S., Falbo, A., Battista, L., Russo, T., Venturella, R., Tolino, A., Orio, F., & Zullo, F. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.11.042 · Cited by 33
Self-citationel Sharkwy, I. A. E. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-2714-2 · Cited by 34
Maged, A. M., Elsawah, H., Abdelhafez, A., Bakry, A., & Mostafa, W. A. I. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1037269 · Cited by 34
“Palomba et al. (2005) found that women with PCOS who received metformin had a nearly similar ovulation rate (63 versus 67”
RetractedIs metformin a primary ovulatory agent in patients with polycystic ovary syndrome?
Cheang, K. I., Sharma, S. T., & Nestler, J. E. (2006) · Gynecological Endocrinology · doi:10.1080/09513590601005847 · Cited by 32
“Palomba and associates conducted the first head-to-head clinical trial comparing metformin to clomiphene as first-line treatment for ovulation induction in women with PCOS who desired pregnancy [24].”
BackgroundResultA 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
Legro, R. S. (2007) · JAMA · doi:10.1001/jama.297.5.509 · Cited by 38
Jt, C., Tominaga, K., Sato, Y., Anzai, H., & Matsuoka, R. (2010) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0696 · Cited by 37
“10,30,31 It is rather interesting that our combination therapy of MSX and CC resulted in the high, improved ovulation rate of 87% (13/15) in those patients who had previously failed with either MSX or CC monotherapy.”
Chen, Z., Liu, L., Xia, X., Burn, M. S., Karakaya, C., & Kallen, A. N. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00700-5 · Cited by 29
Ovulation induction in women with polycystic ovary syndrome
Palomba, S., Orio, F., & Zullo, F. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.018 · Cited by 33
Li, L., Li, C., Pan, P., Chen, X., Wu, X., Ng, E. H. Y., & Yang, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144072 · Cited by 36
“Ovulation rate was calculated as the percentage of ovulatory cycles per total cycles [9].”
Method
Metadata
- Authors
- Palomba, S., Orio, F., Falbo, A., Manguso, F., Russo, T., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F.
- Affiliations
- Magna Graecia University (IT)
- Departments of Molecular and Clinical Endocrinology and Oncology (F.O., T.C., A.C.), 80138 Naples, Italy;
- Internal Medicine (F.M.), 80138 Naples, Italy;
- Federico II University Hospital (IT)
- University of Palermo (IT)
- Corresponding author
- Palomba, Stefano
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-07-01
- Volume
- 90
- Issue
- 7
- Pages
- 4068-4074
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2126438731
- Cited by
- 279
- References
- 43
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 6 · 2020: 6 · 2019: 3 · 2018: 6 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 10 · 2013: 18 · 2012: 17
- FWCI
- 35.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- CINECA IRIS Institutial research information system (Parthenope University of Naples) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- polycystic ovary syndrome, clomiphene citrate, metformin, ovulation induction, anovulation, infertility, pregnancy rate, live birth rate, abortion rates, non-obese women, first-line therapy, ovulation rate, cumulative pregnancy rate, insulin sensitizers, ovulation-inducing drugs
- MeSH terms
- Adult, Anovulation, Clomiphene, Double-Blind Method, Female, Humans, Metformin, Ovulation Induction, Polycystic Ovary Syndrome, Pregnancy, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.